Showing results (1561-1570 of 1,568) with videos related to
Sort By:
Pageof 157
You have reached the last page of results.This site can display upto 1,568 results.
Haematologica|March 6, 2025
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world dataEnrica Antonia Martino, Annalisa Pitino, Massimo Offidani, et al.Immunity|April 10, 2018
The Immune Landscape of CancerVésteinn Thorsson, David L Gibbs, Scott D Brown, et al.European Journal of Haematology|March 19, 2025
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 PatientsFortunato Morabito, Enrica Antonia Martino, Monica Galli, et al.Nature|April 8, 2024
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerUrszula N Wasko, Jingjing Jiang, Tanner C Dalton, et al.Blood Advances|January 7, 2026
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian CohortEnrica Antonia Martino, Annalisa Pitino, Ernesto Vigna, et al.Hematological Oncology|December 29, 2025
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World StudyErnesto Vigna, Enrica Antonia Martino, Annalisa Pitino, et al.Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Genome-wide studies define new genetic mechanisms of IgA vasculitisLili Liu, Li Zhu, Sara Monteiro-Martins, et al.Nature|March 28, 2014
A promoter-level mammalian expression atlas, Alistair R R Forrest, Hideya Kawaji, et al.Pageof 157